FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Degenring

Research Profile

Chemicals & Drugs

Anatomy

Vitreous Body

Physiology

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Andreas K Cordes; Robert F Degenring; Norbert Schrage
[Postoperative care after cataract surgery].
Robert F Degenring; Andreas Cordes; Norbert Schrage
Autologous translocation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration.
Jörg Leu; Norbert Schrage; Robert F Degenring
Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Degenring (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Andreas K Cordes; Robert F Degenring; Norbert Schrage
[Postoperative care after cataract surgery].
Medizinische Monatsschrift für Pharmazeuten 2012;35(4):124-31; quiz 133-4.
2011: Robert F Degenring; Andreas Cordes; Norbert Schrage
Autologous translocation of the retinal pigment epithelium and choroid in the treatment of neovascular age-related macular degeneration.
Acta ophthalmologica 2011;89(7):654-9.
2007: Jörg Leu; Norbert Schrage; Robert F Degenring
Choroidal neovascularisation secondary to Best's disease in a 13-year-old boy treated by intravitreal bevacizumab.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2007;245(11):1723-5.
2007: Bernd A Kamppeter; J B Jonas; Robert F Degenring
[Acute vision loss in oculus ultimus].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2007;104(5):418-21.
2007: Robert F Degenring; Sonja Vey; Bernd A Kamppeter; Wido M Budde; Jost B Jonas; Gangolf Sauder
Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2007;245(1):18-23.
2006: Robert F Degenring; Gangolf Sauder
Vitreous prolapse and IOL dislocation during intravitreal injection of triamcinolone acetonide.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2006;244(8):1043-4.
2006: Jost B Jonas; Ulrich H M Spandau; Bernd A Kamppeter; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun; Urs Vossmerbaeumer
Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration.
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2006;22(3):194-9.
2006: Bernd A Kamppeter; Kirstin V Schubert; Wido M Budde; Robert F Degenring; Jost B Jonas
Optical coherence tomography of the optic nerve head: interindividual reproducibility.
Journal of glaucoma 2006;15(3):248-54.
2006: Ingrid Kreissig; Robert F Degenring; J B Jonas
[Intravitreal triamcinolone acetonide Complication of infectious and sterile endophthalmitis].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2006;103(1):30-4.
2005: Jost B Jonas; Imren Akkoyun; Bernd A Kamppeter; Ingrid Kreissig; Robert F Degenring
Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion.
European journal of ophthalmology 2005;15(6):751-8.
2005: Jost B Jonas; Peter Martus; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun
Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.
Archives of ophthalmology 2005;123(10):1338-43.
2005: Robert F Degenring; Jost B Jonas
Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
Acta ophthalmologica Scandinavica 2005;83(5):621.
2005: Gangolf Sauder; Robert F Degenring; Bernd A Kamppeter; Philipp Hugger
Potential of the 1 CU accommodative intraocular lens.
The British journal of ophthalmology 2005;89(10):1289-92.
2005: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Progress in retinal and eye research 2005;24(5):587-611.
2005: Jost B Jonas; Robert F Degenring; U Vossmerbauemer; Bernd A Kamppeter
Frequency of cataract surgery after intravitreal injection of high-dosage triamcinolone acetonide.
European journal of ophthalmology 2005;15(4):462-4.
2005: Jost B Jonas; Ingrid Kreissig; Wido M Budde; Robert F Degenring
Cataract surgery combined with intravitreal injection of triamcinolone acetonide.
European journal of ophthalmology 2005;15(3):329-35.
2005: Jost B Jonas; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun; Bernd A Kamppeter
Intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
Ophthalmology 2005;112(4):593-8.
2005: Jost B Jonas; Imren Akkoyun; Ingrid Kreissig; Robert F Degenring
Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.
The British journal of ophthalmology 2005;89(3):321-6.
2005: Ingrid Kreissig; Robert F Degenring; Jost B Jonas
[Diffuse diabetic macular edema. Intraocular pressure after intravitreal triamcinolone acetonide].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2005;102(2):153-7.
2005: Jost B Jonas; Robert F Degenring; Ingrid Kreissig; T Friedemann; Imren Akkoyun
Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.
Eye (London, England) 2005;19(2):163-70.
2005: J B Jonas; Ingrid Kreissig; Robert F Degenring; Bernd A Kamppeter
Repeated intravitreal injection of triamcinolone acetonide for diffuse diabetic macular oedema.
The British journal of ophthalmology 2005;89(1):122.
2005: Jost B Jonas; Imren Akkoyun; Bernd A Kamppeter; Ingrid Kreissig; Robert F Degenring
Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide.
Eye (London, England) 2005;19(1):65-71.
2004: Jost B Jonas; Robert F Degenring; Ingrid Kreissig; Imren Akkoyun
Safety of intravitreal high-dose reinjections of triamcinolone acetonide.
American journal of ophthalmology 2004;138(6):1054-5.
2004: Gangolf Sauder; Robert F Degenring; Melanie Jaeger; Caroline Heyer; Jost B Jonas
Phototoxic maculopathy after secondary intraocular lens implantation.
Journal of cataract and refractive surgery 2004;30(12):2620-2.
2004: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.
The British journal of ophthalmology 2004;88(12):1557-62.
2004: Robert F Degenring; Jost B Jonas
Rinsing of the cannula prior to intravitreal injection.
Archives of ophthalmology 2004;122(10):1571-2; author reply 1572.
2004: Robert F Degenring; Insa Aschmoneit; Bernd A Kamppeter; Wido M Budde; Jost B Jonas
Optical coherence tomography and confocal scanning laser tomography for assessment of macular edema.
American journal of ophthalmology 2004;138(3):354-61.
2004: Jost B Jonas; Robert F Degenring; Bernd A Kamppeter; Ingrid Kreissig; Imren Akkoyun
Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema.
American journal of ophthalmology 2004;138(1):158-60.
2004: Robert F Degenring; Jost B Jonas
Serum levels of triamcinolone acetonide after intravitreal injection.
American journal of ophthalmology 2004;137(6):1142-3.
2004: Jost B Jonas; Robert F Degenring; Bernd A Kamppeter
Outcome of eyes undergoing trabeculectomy after intravitreal injections of triamcinolone acetonide.
Journal of glaucoma 2004;13(3):261.
2004: Robert F Degenring; Bernd A Kamppeter; Melanie Jaeger; Thomas Libera; Gangolf Sauder; Jost B Jonas
Subacute visual loss from choroidal metastasis.
Acta ophthalmologica Scandinavica 2004;82(3 Pt 1):304-5.
2004: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Cataract surgery after intravitreal injection of triamcinolone acetonide.
Eye (London, England) 2004;18(4):361-4.
2004: Robert F Degenring; Ingrid Kreissig; Jost B Jonas
[Intraocular triamcinolone for diffuse diabetic macular edema].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2004;101(3):251-4.
2004: Robert F Degenring; Bernd A Kamppeter; Gangolf Sauder; Jost B Jonas
[Transitory reduction of vision without metamorphopsia].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2004;101(2):186-8.
2004: Jost B Jonas; Ingrid Kreissig; Bernd A Kamppeter; Robert F Degenring
[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2004;101(2):113-20.
2004: Jost B Jonas; Imren Akkoyun; Wido M Budde; Ingrid Kreissig; Robert F Degenring
Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.
Archives of ophthalmology 2004;122(2):218-22.
2004: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Retinal complications of intravitreal injections of triamcinolone acetonide.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2004;242(2):184-5.
2004: Robert F Degenring; Philipp Hugger; Gangolf Sauder; Jost B Jonas
[Grid laser photocoagulation in diffuse diabetic macular edema].
Klinische Monatsblätter für Augenheilkunde 2004;221(1):48-51.
2003: Bernd A Kamppeter; Robert F Degenring; J B Jonas
[Readaptation time after photo-stress in normal subjects and glaucoma patients].
Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2003;100(12):1085-90.
2003: Jost B Jonas; Antje Söfker; Jochen Hayler; Robert F Degenring
Intravitreal crystalline triamcinolone acetonide as an additional tool in pars plana vitrectomy for complicated proliferative vitreoretinopathy?
Acta ophthalmologica Scandinavica 2003;81(6):663-5.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Endophthalmitis after intravitreal injection of triamcinolone acetonide.
Archives of ophthalmology 2003;121(11):1663-4.
2003: Robert F Degenring; Bernd A Kamppeter; Ingrid Kreissig; Jost B Jonas
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Acta ophthalmologica Scandinavica 2003;81(5):548-50.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Neovascular glaucoma treated by intravitreal triamcinolone acetonide.
Acta ophthalmologica Scandinavica 2003;81(5):540-1.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Intravitreal triamcinolone acetonide for pseudophakic cystoid macular edema.
American journal of ophthalmology 2003;136(2):384-6.
2003: Robert F Degenring; Bernd A Kamppeter; Ingrid Kreissig; Jost B Jonas
Morphological and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion.
Acta ophthalmologica Scandinavica 2003;81(4):399-401.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.
European journal of ophthalmology 2003;13(6):575-6.
2003: Jost B Jonas; Antje Söfker; Robert F Degenring
Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
European journal of ophthalmology 2003;13(5):468-73.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
[Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
Klinische Monatsblätter für Augenheilkunde 2003;220(6):384-90.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Secondary chronic open-angle glaucoma after intravitreal triamcinolone acetonide.
Archives of ophthalmology 2003;121(5):729-30.
2003: Jost B Jonas; Ingrid Kreissig; Philipp Hugger; Gangolf Sauder; Songhomitra Panda-Jonas; Robert F Degenring
Intravitreal triamcinolone acetonide for exudative age related macular degeneration.
The British journal of ophthalmology 2003;87(4):462-8.
2003: Jost B Jonas; Ingrid Kreissig; Antje Söfker; Robert F Degenring
Intravitreal injection of triamcinolone for diffuse diabetic macular edema.
Archives of ophthalmology 2003;121(1):57-61.
2003: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Intraocular pressure after intravitreal injection of triamcinolone acetonide.
The British journal of ophthalmology 2003;87(1):24-7.
2002: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2002;240(10):873-4.
2002: Jost B Jonas; Ingrid Kreissig; Robert F Degenring
Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie 2002;240(9):782-3.
2002: Jost B Jonas; Robert F Degenring
[Intravitreal injection of crystalline triamcinolone acetonide in the treatment of diffuse diabetic macular oedema].
Klinische Monatsblätter für Augenheilkunde 2002;219(6):429-32.